PR Newswire - MediLink Therapeutics announces a multi-target TMA...
SUZHOU, China, May 27, 2024 /PRNewswire/ -- MediLink Therapeutics (Suzhou) Co., Ltd. ("MediLink"), a clinical-stage biotech company, today announces a new strategic collaboration with BioNTech SE (Nas...
Read More

ภาษาไทย
English